HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

(131)I-ch81C6

human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma, in phase I trial (6/2006)
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sampson, John H: 1 article (06/2006)
2. McLendon, Roger E: 1 article (06/2006)
3. Dowell, Jeannette M: 1 article (06/2006)
4. Friedman, Allan H: 1 article (06/2006)
5. Pegram, Charles N: 1 article (06/2006)
6. Friedman, Henry S: 1 article (06/2006)
7. Provenzale, James M: 1 article (06/2006)
8. Desjardins, Annick: 1 article (06/2006)
9. Badruddoja, Michael A: 1 article (06/2006)
10. Reardon, David A: 1 article (06/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)